Bayer and J&J in drug pact

被引：0

作者：

不详

机构：

来源：

CHEMICAL & ENGINEERING NEWS | 2005年 / 83卷 / 44期

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Bayer and Johnson and Johnson's Ortho-McNeil Pharmaceutical unit have agreed to jointly develop and market Bayer's BAY 59-7939 (Factor Xa inhibitor) for theprevention and treatment of thrombosis.

引用

页码：13 / 13

页数：1

共 50 条

[1] Vertex, J&J in drug pact
不详
CHEMICAL & ENGINEERING NEWS, 2006, 84 (28) : 11 - 11
[2] Emergent and J&J expand vaccine pact
Mullin, Rick
CHEMICAL & ENGINEERING NEWS, 2020, 98 (27) : 13 - 13
[3] J&J BUYS ARAGON FOR CANCER DRUG
不详
CHEMICAL & ENGINEERING NEWS, 2013, 91 (25) : 19 - 19
[4] J&J SEEKS APPROVAL OF TB DRUG
不详
CHEMICAL & ENGINEERING NEWS, 2012, 90 (28) : 15 - 15
[5] J&J deepens TB drug commitment
Jarvis, Lisa
CHEMICAL & ENGINEERING NEWS, 2017, 95 (34) : 15 - 15
[6] ASTELLAS, J&J LINK FOR ARTHRITIS DRUG
不详
CHEMICAL & ENGINEERING NEWS, 2012, 90 (41) : 21 - 21
[7] M. D. ANDERSON, J&J SIGN CANCER PACT
不详
CHEMICAL & ENGINEERING NEWS, 2014, 92 (04) : 15 - 15
[8] J&J pays $250 million for RNAi drug
Cross, Ryan
CHEMICAL & ENGINEERING NEWS, 2018, 96 (41) : 17 - 17
[9] US FDA Expands Approval for J&J HIV Drug
不详
CLINICAL INFECTIOUS DISEASES, 2008, 47 (12) : II - III
[10] J&J to buy TransForm
不详
CHEMICAL & ENGINEERING NEWS, 2005, 83 (11) : 14 - 14

← 1 2 3 4 5 →